Panacea Biotec Limited PEG Ratio

Panacea Biotec Limited's peg ratio stands at 688.8. That is above the Healthcare sector average of 27.75. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Panacea Biotec Limited sits higher the Healthcare benchmark (27.75) with a PEG ratio of 688.8. That is roughly 2382.1% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 688.8 is attractive depends on Panacea Biotec Limited's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Panacea Biotec Limited's PEG ratio evolved across reporting periods, while the comparison chart places PANACEABIO.NS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, PEG ratio is commonly used to spot outliers. Panacea Biotec Limited's reading of 688.8 (sector avg 27.75) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.